Insider Shareholders with Direct Ownership of Protara Therapeutics, Inc. (TARA)
This section provides a comprehensive overview of the insiders with direct ownership of Protara Therapeutics, Inc. (TARA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Protara Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Jesse Shefferman
CEO and President |
313,665 | 400,485 | 1,046,886 $5.77 Million | 21 |
Jan 16, 2026
Added 7.67%
|
| 30,000 | 0 | 198,000 $1.09 Million | 3 |
Jun 30, 2022
Added 4.81%
|
|
|
Jacqueline Zummo
Chf Scientific Operations Off |
111,500 | 56,752 | 128,861 $710,024 | 15 |
Jan 16, 2026
Added 18.88%
|
|
Leonardo Viana Nicacio
Chief Medical Officer |
76,000 | 0 | 78,181 $430,777 | 2 |
Jan 16, 2026
Added 24.96%
|
|
William Conkling
Chief Commercial Officer |
76,000 | 0 | 76,000 $418,760 | 2 |
Jan 16, 2026
Added 25.49%
|
|
Patrick Fabbio
Chief Financial Officer |
73,500 | 3,061 | 70,439 $388,118 | 4 |
Jan 16, 2026
Added 28.44%
|
|
Jathin Bandari
Chief Medical Officer |
57,200 | 7,996 | 56,704 $312,439 | 8 |
Jan 19, 2024
Reduced 4.83%
|
| 20,000 | 0 | 51,000 $281,010 | 1 |
May 14, 2025
Added 28.17%
|
|
|
Hannah Fry
VP, Controller |
57,900 | 14,188 | 46,312 $255,179 | 11 |
Jan 16, 2026
Added 17.02%
|
|
Blaine Davis
Chief Financial Officer |
14,100 | 5,081 | 20,662 $113,847 | 2 |
Jul 15, 2022
Reduced 19.74%
|
|
Martin Sebastian Olivo
Chief Medical Officer |
9,893 | 0 | 14,344 $79,035 | 1 |
Jun 10, 2021
Added 25.59%
|